ABSTRACT

S. Rept. 115-285: Opioid Addiction Recovery Fraud Prevention Act of 2018, Report of the Committee on Commerce, Science, and Transportation on S. 2842, June 27, 2018   [open pdf - 263KB]

Alternate Title: Senate Report 115-285: Opioid Addiction Recovery Fraud Prevention Act of 2018, Report of the Committee on Commerce, Science, and Transportation on S. 2842, January 27, 2018

"The Committee on Commerce, Science, and Transportation, to which was referred the bill (S. 2842) to prohibit the marketing of bogus opioid treatment programs or products, having considered the same, reports favorably thereon with an amendment (in the nature of a substitute) and recommends that the bill (as amended) do pass. The purpose of S. 2842, the Opioid Addiction Recovery Fraud Prevention Act of 2018, is to explicitly prohibit the deceptive marketing of opioid treatment programs and products. Section 5 of the Federal Trade Commission Act (FTC Act; 15 U.S.C. 41 et seq.) already prohibits such deceptive practices. The bill also would provide additional tools to the Federal Trade Commission (FTC) and States to enforce against these practices."

Report Number:
S. Rept. 115-285; Senate Report 115-285
Publisher:
Date:
2018
Copyright:
Public Domain
Retrieved From:
U.S. Government Publishing Office: http://www.gpo.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations